February 2026

B Braun nerve stimulators, such as the Stimuplex HNS 12, deliver precise peripheral nerve blocks for regional anesthesia, enhancing surgical outcomes and patient recovery. These battery-powered devices offer adjustable stimulation currents up to 5 mA, SENSe technology for rapid nerve localization, and safety alarms to minimize risks. Clinics gain operational efficiency through dependable access to […]

Central venous catheter (CVC) procedures face rising demand due to critical care needs, with over 5 million insertions annually in the US alone. The Certofix nerve stimulator replacement from B. Braun integrates ECG-guided positioning to reduce complications like malposition by up to 90%, ensuring precise tip placement during Seldinger insertions. This upgrade supports multi-lumen access

The B Braun Certofix nerve stimulator, featuring advanced SENSe technology, delivers precise peripheral nerve location for single and continuous nerve blocks, enhancing procedural accuracy and patient safety. Clinics sourcing this equipment through HHG GROUP benefit from verified availability, reducing downtime and ensuring compliance with medical standards across global operations. How Has the Peripheral Nerve Blockade

The B. Braun 4892098 nerve stimulator delivers precise peripheral nerve blocks for anesthesia, enabling safer regional procedures with up to 95% first-attempt success rates in surgeries. This device supports pain management for over 50 million annual procedures worldwide, reducing opioid use by 40%. HHG GROUP offers a secure marketplace for new and used replacements, ensuring

Central venous catheters like the B Braun Certofix surgical stimulator enable precise vessel access in critical care, reducing complications and improving patient outcomes. This advanced device supports ultrasound-guided placement and ECG-based tip positioning, minimizing infection risks and ensuring hemodynamic stability across ICUs, operating rooms, and oncology units. Healthcare providers rely on it for administering high-osmolarity

In the field of urology, benign prostatic hyperplasia (BPH) affects over 50% of men aged 60 and older, leading to urinary symptoms that disrupt daily life. The Rezum surgical tool handle assembly offers a minimally invasive solution that delivers water vapor therapy to shrink prostate tissue, providing rapid symptom relief while preserving sexual function and

Benign prostatic hyperplasia (BPH) affects over 100 million men globally, with Rezum water vapor therapy from Boston Scientific offering a minimally invasive solution that reduces prostate tissue and relieves symptoms in a single outpatient procedure. The M006D2201-0031 delivery device kit enables precise steam injections, improving urinary flow by up to 50% within months while preserving

Benign prostatic hyperplasia (BPH) affects millions of men worldwide, driving demand for effective treatments like the Boston Scientific Rezum system. The Rezum device handle part is critical for delivering water vapor therapy, enabling precise prostate tissue reduction with minimal invasiveness. Clinics rely on this component for safe, outpatient procedures that improve urinary symptoms and quality

In the current global medical equipment market, precision, safety, and product traceability have become non‑negotiable standards. The Boko Rezum Handle Part Number M006D2201‑0031 delivers a next‑generation solution that ensures consistent performance across urology and endoscopic treatment systems, addressing the crucial need for reliable and verified components that medical institutions can trust. How Is the Medical